NECLIFENSENectar Lifesciences Limited· PharmaceuticalsLowNeutral
Announced Tue, 19 Aug · 11:39 IST

NECLIFE: Nectar Lifesciences Limited has informed the Exchange about "Saksham Niveshak" Campaign- Shareholder Outreach Initiative.

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nectar Lifesciences Limited has launched a 100-day 'Saksham Niveshak' outreach campaign from July 28, 2025, to November 6, 2025, under the guidance of the IEPF Authority, Ministry of Corporate Affairs. The campaign aims to help shareholders update their KYC details (bank account mandates, nominee registration, email, mobile, address) and claim unpaid or unclaimed dividends. The company has sent notices to 164 shareholders whose dividends have remained unclaimed for seven consecutive years, warning that unpaid dividends from FY 2017-18 along with corresponding shares are liable to be transferred to the IEPF Authority. Newspaper advertisements have been published in Business Standard and Desh Sewak on July 16, 2025, and shareholders have been directed to contact the company's RTA, KFin Technologies Limited, to take prompt action.

Likely market impact

This is a routine regulatory outreach to protect shareholders from losing their unclaimed dividends and shares to the IEPF. Investors holding Nectar Lifesciences shares should check if they have any unclaimed dividends and update their KYC promptly to avoid transfer of their assets to the government fund. No direct impact on stock price is expected from this announcement.